Floatz logo

Therapeutic Asset Ratings

6,308 results matching 1 filter

91,564 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Tarlatamab
Sinonasal Undifferentiated Carcinoma
University of ArizonaP1/2CCC (48)
TAS0953
Non-Small Cell Lung Carcinoma
Taiho Pharmaceutical Co., Ltd.P1/2CCC (48)
TAS0953
RET Fusion Positive Cancer
Taiho Pharmaceutical Co., Ltd.P1/2CCC (48)
Tazemetostat
Metastatic Prostate Carcinoma
Dana-Farber Cancer InstituteP1/2CCC (48)
Tbi-1501
Adult Acute Lymphoblastic Leukemia
Takara Bio Inc.P1/2CCC (48)
Tb-Psma-I&T
Prostate Cancer
Rabin Medical CenterP1/2CCC (48)
tc011
High Grade B-Cell Lymphoma
TICAROS Co., Ltd.P1/2CCC (48)
tc011
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
TICAROS Co., Ltd.P1/2CCC (48)
tc011
Follicular Lymphoma
TICAROS Co., Ltd.P1/2CCC (48)
tc-510
Peritoneal Mesothelioma
TCR2 TherapeuticsP1/2CCC (48)
tc-510
Pleural Mesothelioma
TCR2 TherapeuticsP1/2CCC (48)
tc-510
Ovarian Adenocarcinoma
TCR2 TherapeuticsP1/2CCC (48)
tcc1727
Cancer
Beijing Tide Pharmaceutical Co., LtdP1/2CCC (48)
Tcr Reserved And Power3 (Sppl3) Gene Knock-Out Allogeneic Cd19-Targeting Car-T Cell
Non-Hodgkin Lymphoma
Chinese PLA General HospitalP1/2CCC (48)
T-Dxd
Biliary Tract Cancer
AstraZenecaP1/2CCC (48)
T-Dxd
Small Cell Lung Carcinoma
AstraZenecaP1/2CCC (48)
TE-8105
Obesity Disorder
Immunwork, Inc.P1/2CCC (48)
Teclistamab
Myelodysplastic Syndrome
CellCentric Ltd.P1/2CCC (48)
Tegavivint
Classic Familial Adenomatous Polyposis
HonorHealth Research InstituteP1/2CCC (48)
Tegavivint
CTNNB1-Related Neurodevelopmental Disorder And/Or Vitreoretinopathy
HonorHealth Research InstituteP1/2CCC (48)
Tegavivint
Endometrial Carcinoma
Children's Oncology GroupP1/2CCC (48)
Tegavivint
Desmoid Tumor
Children's Oncology GroupP1/2CCC (48)
Tegavivint
Ewing Sarcoma
Children's Oncology GroupP1/2CCC (48)
Tegavivint
Hepatoblastoma
Children's Oncology GroupP1/2CCC (48)
Tegavivint
Non-Hodgkin Lymphoma
Children's Oncology GroupP1/2CCC (48)
Showing 1876 to 1900 of 6,308 assets
PreviousPage 76 of 253Next